Symptom experiences in patients with advanced pancreatic cancer as reported during healthcare encounters

Abstract

Symptom management is one of the primary goals of care for advanced pancreatic cancer (APC) patients. The purpose of this study was to examine recorded healthcare encounters to better understand the symptom experiences of APC patients as told to healthcare providers (HCP). In this qualitative descriptive study, content analysis was used to analyze 37 transcripts of audio-recorded, naturally occurring encounters among APC patients, caregivers, and HCP. Transcripts were drawn from a larger randomized controlled study, which recruited advanced cancer patients and caregivers across the United States. Findings revealed that APC patients and caregivers experienced multiple troubling symptoms. Thirty-seven APC patients and 34 caregivers discussed 10 types of symptoms: pain, fatigue, abnormal bowel movements, decreased appetite, nausea and vomiting, sleeping problems, neurological problems, skin problems, psychological distress, and taste changes. The patients and caregivers discussed various aspects of the symptoms, including the nature of the symptoms, how the symptoms affected their lives, and the way they managed symptoms. Some symptoms were described as severe, life-changing, and highly distressing. HCP should be attuned to the wide variety of ways in which APC patients experience, manage, and live with symptoms. A systematic approach to address symptoms during encounters may improve care and efficiency.

Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects—results from the POUDER pilot study

“…Although only patients who were able to take in food orally without indigestion or problems with food passage were included, patients with advanced PDA often rapidly progress from a healthy status to the terminal stage, and the progression is accompanied by a variety of severe side effects [30]. This may have been a major reason why several patients stopped participating in the study without providing a reason.…”

What narrative devices do people with systemic sclerosis use to describe the experience of pain from digital ulcers: a multicentre focus group study at UK scleroderma centres

“…We have identified five narrative devices: describing pain sensations; describing the physical and psychological reaction to the pain; comparisons with other painful events or imagined extreme solutions to unbearable pain; descriptions of factors that exacerbate pain and limits participation in the world; and describing the strategies for coping with the pain. These narrative devices resonate with the lived experience of pain described by people with SSc, 1 11 Raynaud's phenomenon 42 43 and other conditions (eg, osteoarthritis, 20 pancreatic cancer, 21 dysmenorrhoea, 44 necrotising fasciitis, 45 acute intermittent porphyria 22 ).…”

“…11 Previous qualitative research in other diagnoses has investigated more deeply how pain is experienced and expressed and how it interferes with one's life. [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34] One of the problems inherent in how we respond clinically to pain is that when pain is assessed it is often measured, with a focus on pain intensity using quantitative scales. 23 However, there is an indication that patients use different approaches when rating pain intensity on scales such as the Brief Pain Inventory (BPI), which includes considering how pain fluctuates as well as the location and duration of the pain.…”

Characteristics of taste alterations in people receiving taxane-based chemotherapy and their association with appetite, weight, and quality of life

“…In addition, patients receiving nab-PTX are only with pancreatic cancer that is probably higher staged of the disease due to clinical indication of nab-PTX for pancreatic cancer. Taste alteration itself can be a symptom of the disease in such advanced stage [35]. Regarding DTX, the [6].…”